MedTrace Logo

Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)

NCT02990598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2019-08-26

No results posted yet for this study

Summary

To examine the pharmacokinetics and distribution of oral hydroxyurea when administered as a single dose to lactating women

Conditions

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Russell Ware, MD, PhD · Children's Hospital Medical Center, Cincinnati

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-20
Primary Completion
2018-06-19
Completion
2018-06-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02990598 on ClinicalTrials.gov